-

Drugs

  • Share Share this page

Zanamivir (marketed as Relenza) Information

Zanamivir is approved for treatment of acute uncomplicated illness due to influenza A and B in patients 7 years of age and older. It is also approved for preventive use (prophylaxis) in patients 5 years of age and older.

    
-

Labeling and Regulatory History from Drugs@FDA

-
 

Contact Us

  • Human Drug Information

  • (888) 463-6332
  • (301) 796-3400
  • Division of Drug Information (CDER)

    Office of Training and Communication

    Feedback Form

    WO51-2201

    10903 New Hampshire Avenue

    Silver Spring, MD 20993

-
-
-
-
-
-